American Well: The Doctor Will E-See You Now Custom Case Solution & Analysis

1. Evidence Brief (Case Researcher)

Financial Metrics

• Market Opportunity: The US telehealth market was valued at $1.2B in 2012, projected to reach $4.5B by 2018 (Exhibit 1).
• Revenue Model: American Well (AW) generates revenue through a combination of platform licensing fees to health systems/insurers and per-consultation fees (Case text, p. 5).
• Cost Structure: High fixed costs in software development and server infrastructure; variable costs per consult include physician compensation and clinical oversight (Case text, p. 7).

Operational Facts

• Product: AW provides a two-sided platform connecting patients with physicians via video, phone, or secure messaging (Case text, p. 2).
• Distribution: AW operates a B2B2C model, selling its platform to insurers (e.g., Anthem, UnitedHealth) and large provider networks who then offer it to their members/patients (Case text, p. 4).
• Regulatory Environment: State-by-state licensing requirements for physicians remain the primary barrier to national scaling (Case text, p. 9).

Stakeholder Positions

• Roy Schoenberg (CEO): Advocates for a B2B2C approach, positioning AW as a technology partner rather than a competitor to existing health systems (Case text, p. 6).
• Health Systems: Fear telehealth will cannibalize in-person visits and disrupt referral patterns (Case text, p. 8).
• Insurers: Motivated by cost reduction; telehealth reduces expensive ER and urgent care utilization (Case text, p. 5).

Information Gaps

• AW specific EBITDA or cash burn rate (Not provided).
• Conversion rates of patients from initial telehealth consult to follow-up in-person care (Not provided).

2. Strategic Analysis (Strategic Analyst)

Core Strategic Question

How should American Well accelerate adoption while navigating the conflicting incentives of health systems, insurers, and regulators?

Structural Analysis

• Bargaining Power of Buyers: High. Large insurers dictate contract terms. AW lacks sufficient differentiation to ignore these demands.
• Threat of Substitutes: High. Direct-to-consumer (DTC) telehealth entrants and primary care physician (PCP) in-office visits remain the default.
• Regulatory Barriers: High. Physician licensure laws prevent the creation of a national, frictionless physician pool.

Strategic Options

• Option 1: The Partner Model (Current). Continue licensing to health systems. Trade-offs: Slow adoption, high integration friction, but preserves long-term institutional relationships.
• Option 2: The Aggregator Model. Pivot to a consumer-facing brand, bypassing provider resistance. Trade-offs: High marketing spend, risk of alienating provider partners, potentially faster market penetration.
• Option 3: The Infrastructure Play. Focus exclusively on the backend platform (API-first) for other digital health startups. Trade-offs: Lower margins, loss of brand equity, but higher scalability.

Preliminary Recommendation

Pursue a hybrid of Option 1 and 3. The B2B2C model is the only path that mitigates provider resistance. By shifting to an API-first backend, AW can reduce the friction of integration, effectively making it the plumbing for the entire telehealth market.

3. Implementation Roadmap (Implementation Specialist)

Critical Path

1. Standardize API Documentation: Develop a self-service developer portal to allow health systems to integrate AW features into their own patient portals within 30 days.
2. Regulatory Lobbying: Form a coalition with partner insurers to lobby for the Interstate Medical Licensure Compact to simplify cross-state practice.
3. Clinical Integration: Build automated data-sharing protocols to push telehealth consult notes directly into the health systems' Electronic Health Records (EHR) in real-time.

Key Constraints

• EHR Compatibility: Integration with legacy systems (Epic, Cerner) is technically complex and time-consuming.
• Provider Adoption: If physicians view telehealth as an administrative burden, they will not use it, regardless of the technology.

Risk-Adjusted Implementation

Focus on a pilot program with three mid-sized provider networks. If adoption does not reach 15% of eligible patient visits within six months, revert to an insurer-led direct-to-patient model to bypass the provider bottleneck entirely.

4. Executive Review (Executive Critic)

BLUF

American Well is currently a technology vendor in a market that demands a clinical network. The current strategy assumes health systems will embrace a tool that cannibalizes their primary revenue stream. They will not. The company should stop attempting to integrate with every hospital system and instead focus on becoming the exclusive telehealth partner for large, self-insured employers and national insurers. This bypasses the hospital resistance and aligns the revenue model with those who actually pay for the care: the payers. If the company continues to prioritize hospital partnerships, it will remain a low-margin software shop while competitors capture the consumer experience.

Dangerous Assumption

The assumption that health systems will adopt a platform that disrupts their own fee-for-service business model is fundamentally flawed. They are structurally incentivized to reject or minimize telehealth adoption.

Unaddressed Risks

• Clinical Liability: As volume scales, the risk of malpractice suits involving remote diagnosis increases. This is not sufficiently addressed in the current plan.
• Data Security: A single breach of patient records will terminate institutional partnerships. The plan lacks a dedicated cybersecurity investment roadmap.

Unconsidered Alternative

Acquisition of a mid-sized urgent care chain. Owning the physical footprint would allow AW to control the full care continuum and force the integration of telehealth as a standard intake step, rather than an optional add-on.

Verdict

REQUIRES REVISION. The strategy must pivot from being a software vendor to a clinical partner. The current reliance on hospital partnerships is a strategic dead end.